Following the success of our inaugural RNAi meeting in London in November 2003 C5 has once again brought together some of the world's leading academic scientists and industry researchers to present and discuss exciting new results in RNAi, siRNA and microRNA and their impact on drug discovery.
Our leading global speaker panel will provide you with a critical update and share their unique insights on the latest developments in the field of RNAi, including:

• Basic biology of RNAi through product development
• MicroRNAs in a disease context: Diabetes
• RNAi in oncology target validation and discovery
• RNAi for cell-based screens: Limitations and opportunities
• Developing siRNA-based therapeutics
• Large-scale vector-based screens in cultured mammalian cells
• Alternative approaches to silence genes
• Delivery of siRNA in vivo